Development of an Ambulatory Pump Program to Enhance Safety for Patients Enrolled in Clinical Trials

2.50
Hdl Handle:
http://hdl.handle.net/10755/164865
Category:
Abstract
Type:
Presentation
Title:
Development of an Ambulatory Pump Program to Enhance Safety for Patients Enrolled in Clinical Trials
Author(s):
Rattner, Barbara
Author Details:
Barbara Rattner, Massachusetts General Hospital, Boston, Massachusetts, USA
Abstract:
Background & Rationale: The Massachusetts General Hospital Cancer Center has expanded patient participation in clinical trials by 50% over the past three years. Many of these clinical trials require patients to receive medication via continuous infusion. A variety of ambulatory infusion pumps were being used for the delivery of both standard and investigational chemotherapy. Nurses identified a high risk for error because each pump had different specifications, programming, and operation requirements. Additionally, home infusion companies are not licensed to monitor drugs in development. This meant that patients receiving investigational agents at home were not eligible for home nursing visits, adding to the misgivings of staff. In response to these concerns, the nursing leadership initiated the development of a program to address these patient safety issues. Interventions: A multi-disciplinary committee was convened to examine our existing resources and ability to manage a self-contained ambulatory care investigational drug program. One infusion pump was selected which utilizes bar-code technology and eliminates the potential for human error in the programming process. A pilot project was undertaken with conventional, non-vesicant infusional therapy considered a lower risk for patient adverse events. Patients and families attended a structured education program developed and presented by a nurse prior to initiating therapy. Twenty-four hour nursing telephone coverage was provided. Interpretation: Product reliability testing conducted by our biomedical engineering department demonstrated safe, reliable delivery rates. Safer pump technology along with a structured patient/family education process created an environment of acceptance among our patients and professional staff. On-call nursing utilization for patient care issues was minimal. After evaluating the results from the pilot project, the program was expanded to incorporate patients enrolled in clinical trials. Discussion: The ambulatory pump program is ready to meet the growing demands of our clinical trials program. Physicians and nurses have confidence in this program and technology. Investigators are now mandated to use this pump for trials involving continuous infusions, eliminating the danger of multiple infusion pumps.
Repository Posting Date:
27-Oct-2011
Date of Publication:
27-Oct-2011
Conference Date:
2002
Conference Name:
27th Annual Oncology Nursing Society Congress
Conference Host:
Oncology Nursing Society
Conference Location:
Washington, D.C., USA
Note:
This is an abstract-only submission. If the author has submitted a full-text item based on this abstract, you may find it by browsing the Virginia Henderson Global Nursing e-Repository by author. If author contact information is available in this abstract, please feel free to contact him or her with your queries regarding this submission. Alternatively, please contact the conference host, journal, or publisher (according to the circumstance) for further details regarding this item. If a citation is listed in this record, the item has been published and is available via open-access avenues or a journal/database subscription. Contact your library for assistance in obtaining the as-published article.

Full metadata record

DC FieldValue Language
dc.type.categoryAbstracten_US
dc.typePresentationen_GB
dc.titleDevelopment of an Ambulatory Pump Program to Enhance Safety for Patients Enrolled in Clinical Trialsen_GB
dc.contributor.authorRattner, Barbaraen_US
dc.author.detailsBarbara Rattner, Massachusetts General Hospital, Boston, Massachusetts, USAen_US
dc.identifier.urihttp://hdl.handle.net/10755/164865-
dc.description.abstractBackground & Rationale: The Massachusetts General Hospital Cancer Center has expanded patient participation in clinical trials by 50% over the past three years. Many of these clinical trials require patients to receive medication via continuous infusion. A variety of ambulatory infusion pumps were being used for the delivery of both standard and investigational chemotherapy. Nurses identified a high risk for error because each pump had different specifications, programming, and operation requirements. Additionally, home infusion companies are not licensed to monitor drugs in development. This meant that patients receiving investigational agents at home were not eligible for home nursing visits, adding to the misgivings of staff. In response to these concerns, the nursing leadership initiated the development of a program to address these patient safety issues. Interventions: A multi-disciplinary committee was convened to examine our existing resources and ability to manage a self-contained ambulatory care investigational drug program. One infusion pump was selected which utilizes bar-code technology and eliminates the potential for human error in the programming process. A pilot project was undertaken with conventional, non-vesicant infusional therapy considered a lower risk for patient adverse events. Patients and families attended a structured education program developed and presented by a nurse prior to initiating therapy. Twenty-four hour nursing telephone coverage was provided. Interpretation: Product reliability testing conducted by our biomedical engineering department demonstrated safe, reliable delivery rates. Safer pump technology along with a structured patient/family education process created an environment of acceptance among our patients and professional staff. On-call nursing utilization for patient care issues was minimal. After evaluating the results from the pilot project, the program was expanded to incorporate patients enrolled in clinical trials. Discussion: The ambulatory pump program is ready to meet the growing demands of our clinical trials program. Physicians and nurses have confidence in this program and technology. Investigators are now mandated to use this pump for trials involving continuous infusions, eliminating the danger of multiple infusion pumps.en_GB
dc.date.available2011-10-27T12:08:23Z-
dc.date.issued2011-10-27en_GB
dc.date.accessioned2011-10-27T12:08:23Z-
dc.conference.date2002en_US
dc.conference.name27th Annual Oncology Nursing Society Congressen_US
dc.conference.hostOncology Nursing Societyen_US
dc.conference.locationWashington, D.C., USAen_US
dc.description.noteThis is an abstract-only submission. If the author has submitted a full-text item based on this abstract, you may find it by browsing the Virginia Henderson Global Nursing e-Repository by author. If author contact information is available in this abstract, please feel free to contact him or her with your queries regarding this submission. Alternatively, please contact the conference host, journal, or publisher (according to the circumstance) for further details regarding this item. If a citation is listed in this record, the item has been published and is available via open-access avenues or a journal/database subscription. Contact your library for assistance in obtaining the as-published article.-
All Items in this repository are protected by copyright, with all rights reserved, unless otherwise indicated.